Protagonist Therapeutics's market cap is currently $2.29B. The company's EPS TTM is $2.665; its P/E ratio is 14.44; Protagonist Therapeutics is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $0.38. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 60.00M	$ 26.58M	$ 27.36M	$ 28.63M	$ 231.00K
Gross Profit	$ 60.00M	$ 25.55M	$ 24.58M	$ 28.63M	$ 231.00K
Operating Income	$ -93.65M	$ -131.37M	$ -125.84M	$ -64.52M	$ -80.52M
EBITDA	$ -90.34M	$ -131.37M	$ -123.07M	$ -63.66M	$ -78.31M
Net Income	$ -78.95M	$ -123.41M	$ -122.63M	$ -66.15M	$ -77.19M
Balance Sheet
Cash & Short-Term Investments	$ 341.62M	$ 237.35M	$ 326.90M	$ 307.81M	$ 133.02M
Total Assets	$ 357.95M	$ 247.93M	$ 347.69M	$ 324.47M	$ 154.92M
Total Debt	$ 1.14M	$ 3.66M	$ 5.86M	$ 5.96M	$ 17.01M
Net Debt	$ -185.59M	$ -122.09M	$ -117.81M	$ -111.40M	$ -15.99M
Total Liabilities	$ 21.27M	$ 784.68M	$ 47.67M	$ 44.86M	$ 74.95M
Stockholders' Equity	$ 336.68M	$ -536.75M	$ -409.36M	$ -283.81M	$ -217.66M
Cash Flow
Free Cash Flow	$ -70.84M	$ -108.93M	$ -108.97M	$ -72.95M	$ -42.49M
Operating Cash Flow	$ -70.24M	$ -108.14M	$ -107.86M	$ -72.48M	$ -41.53M
Investing Cash Flow	$ -39.26M	$ 91.47M	$ -15.86M	$ -90.97M	$ -53.71M
Financing Cash Flow	$ 170.48M	$ 18.84M	$ 129.92M	$ 247.63M	$ 46.04M

Currency in USD

Protagonist Therapeutics Earnings and Revenue History

Income Statement >

Protagonist Therapeutics Debt to Assets

Balance Sheet >

Protagonist Therapeutics Cash Flow

Cash Flow >

Protagonist Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing